Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 259

1.

Polymeric "smart" coatings to prevent foreign body response to implantable biosensors.

Wang Y, Papadimitrakopoulos F, Burgess DJ.

J Control Release. 2013 Aug 10;169(3):341-7. doi: 10.1016/j.jconrel.2012.12.028. Epub 2013 Jan 5.

PMID:
23298616
2.
3.

Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control.

Patil SD, Papadimitrakopoulos F, Burgess DJ.

Diabetes Technol Ther. 2004 Dec;6(6):887-97.

PMID:
15684644
4.

PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation.

Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ.

Int J Pharm. 2010 Jan 15;384(1-2):78-86. doi: 10.1016/j.ijpharm.2009.09.046. Epub 2009 Oct 2.

PMID:
19800956
5.

Microsphere erosion in outer hydrogel membranes creating macroscopic porosity to counter biofouling-induced sensor degradation.

Vaddiraju S, Wang Y, Qiang L, Burgess DJ, Papadimitrakopoulos F.

Anal Chem. 2012 Oct 16;84(20):8837-8845. doi: 10.1021/ac3022423. Epub 2012 Oct 5.

6.

Foreign Body Reaction to Implantable Biosensors: Effects of Tissue Trauma and Implant Size.

Wang Y, Vaddiraju S, Gu B, Papadimitrakopoulos F, Burgess DJ.

J Diabetes Sci Technol. 2015 Aug 25;9(5):966-77. doi: 10.1177/1932296815601869.

7.

Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants.

Kastellorizios M, Papadimitrakopoulos F, Burgess DJ.

J Control Release. 2015 Sep 28;214:103-11. doi: 10.1016/j.jconrel.2015.07.021. Epub 2015 Jul 26.

PMID:
26216396
8.

Drug Distribution in Microspheres Enhances Their Anti-Inflammatory Properties in the Gottingen Minipig.

Kastellorizios M, Tipnis N, Papadimitrakopoulos F, Burgess DJ.

Mol Pharm. 2015 Sep 8;12(9):3332-8. doi: 10.1021/acs.molpharmaceut.5b00326. Epub 2015 Aug 10.

PMID:
26237140
9.

Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.

Shen J, Burgess DJ.

Int J Pharm. 2012 Jan 17;422(1-2):341-8. doi: 10.1016/j.ijpharm.2011.10.020. Epub 2011 Oct 13. Erratum in: Int J Pharm. 2012 Jun 15;429(1-2):168.

10.

In vitro and in vivo performance of dexamethasone loaded PLGA microspheres prepared using polymer blends.

Gu B, Wang Y, Burgess DJ.

Int J Pharm. 2015 Dec 30;496(2):534-40. doi: 10.1016/j.ijpharm.2015.10.056. Epub 2015 Oct 28.

11.

In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.

Norton LW, Tegnell E, Toporek SS, Reichert WM.

Biomaterials. 2005 Jun;26(16):3285-97.

PMID:
15603824
12.

A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors.

Bhardwaj U, Papadimitrakopoulos F, Burgess DJ.

J Diabetes Sci Technol. 2008 Nov;2(6):1016-29.

13.
14.

Prevention of foreign body reaction in a pre-clinical large animal model.

Kastellorizios M, Papadimitrakopoulos F, Burgess DJ.

J Control Release. 2015 Mar 28;202:101-7. doi: 10.1016/j.jconrel.2015.01.038. Epub 2015 Jan 30.

PMID:
25645376
15.

A dexamethasone-loaded PLGA microspheres/collagen scaffold composite for implantable glucose sensors.

Ju YM, Yu B, West L, Moussy Y, Moussy F.

J Biomed Mater Res A. 2010 Apr;93(1):200-10. doi: 10.1002/jbm.a.32512.

PMID:
19536830
16.

Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.

Patil SD, Papadmitrakopoulos F, Burgess DJ.

J Control Release. 2007 Jan 22;117(1):68-79. Epub 2006 Oct 19.

PMID:
17169457
17.

A miniaturized transcutaneous system for continuous glucose monitoring.

Croce RA Jr, Vaddiraju S, Kondo J, Wang Y, Zuo L, Zhu K, Islam SK, Burgess DJ, Papadimitrakopoulos F, Jain FC.

Biomed Microdevices. 2013 Feb;15(1):151-60. doi: 10.1007/s10544-012-9708-x.

18.

Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices.

Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ.

J Diabetes Sci Technol. 2007 Jan;1(1):8-17.

19.

Modulation of the foreign body response to implanted sensor models through device-based delivery of the tyrosine kinase inhibitor, masitinib.

Avula MN, Rao AN, McGill LD, Grainger DW, Solzbacher F.

Biomaterials. 2013 Dec;34(38):9737-46. doi: 10.1016/j.biomaterials.2013.08.090. Epub 2013 Sep 20.

PMID:
24060424
20.

Porous, Dexamethasone-loaded polyurethane coatings extend performance window of implantable glucose sensors in vivo.

Vallejo-Heligon SG, Brown NL, Reichert WM, Klitzman B.

Acta Biomater. 2016 Jan;30:106-115. doi: 10.1016/j.actbio.2015.10.045. Epub 2015 Oct 29.

Supplemental Content

Support Center